Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Bifidobacterium breve Rosell-70 and Improved Depressive Symptoms

Research synthesisLow evidenceModerate effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies (all reviews), all reported beneficial effects on depressive symptoms, with effect sizes ranging from small to moderate (predominantly moderate). The evidence is based on reviews of psychobiotics/probiotics, not exclusively on Bifidobacterium breve Rosell-70. The small number of studies limits certainty.

  • Studied populations: adults

Caveats: Available evidence is overwhelmingly positive but derived from reviews of multiple probiotics; only 3 studies, none specifically on Bifidobacterium breve Rosell-70 in isolation. Evidence base is small — conclusions should be considered preliminary. Clinical literature in this area is subject to publication bias (null-result studies less likely to be published).

Generated May 12, 2026
3 of 3 papers
Back to top